Recipharm partners with CTC to reduce complexity of first-in-human studies

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/Gajus)
(Image: iStock/Gajus)

Related tags: Clinical trial, Contract research organization

Recipharm is collaborating with the Swedish contract research organization (CRO) to provide a “start to finish service,” says the CDMO.

Clinical Trial Consultants (CTC) supports customers with hospital-based early phase clinical trials, including patient recruitment, trial design, implementation and data evaluation.

The newly launched Recipharm Pathway to Clinic will take projects from early phase formulation development through clinical trial implementation, according to the company.

We have worked together on various projects in the past and found that the partnership works well​,” Torkel Gren, general manager at Recipharm Pharmaceutical Development AB told

In 2014, the companies teamed up​ in a collaboration focused on producing materials for Phase I clinical trials.

Additionally, CTC’s site in Uppsala is geographically close to Recipharm’s sites in Uppsala and Solna, at which the CDMO performs formulation development, GMP clinical supply manufacture, and bioanalysis.

The proximity will facilitate the transfer of clinical trial material and samples, said Gren.

We can offer our customers a start to finish service, which reduces the complexity of first in human studies for them and speed the process up as a result of seamless coordination with Recipharm providing clinical trial material and CTC planning and conducting the actual study​,” he added.

Recipharm will also analyze samples during or after trial completion.

As for the next steps, Gren said the company will hopefully be able to build on the current offering to help customers with bioequivalence studies and bioavailability studies as well as first in human studies. 

Related news

Related products

show more

Liver Disease Capabilities

Liver Disease Capabilities

Q² Solutions | 01-Oct-2020 | Clinical Study

We integrate therapeutic insights, state-of-the-art technologies, best-in-class methods and quality systems to optimize NAFLD & NASH study design,...

What to consider when working with CRFs

What to consider when working with CRFs

Formedix | 21-Sep-2020 | Technical / White Paper

For a study to be successful, data collected must be correct and complete. To be correct and complete, forms must be well planned with meticulous attention...

Innovations in OSD

Innovations in OSD

Recorded the 06-Oct-2020 | Webinar

This DFE series of educational webinars looks at innovations in Oral Solid Dose Forms with the emergence of advanced technologies such as Continuous Manufacturing...

Register for free

Related suppliers

Follow us


View more